Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series

BACKGROUND: Intravenous (IV) zanamivir could be a suitable alternative for the treatment of severe influenza A(H1N1)pdm09 infection in patients who are unable to take oral or inhaled medication, for example, those on mechanical ventilation and extracorporeal membrane oxygenation (ECMO). However, dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Torti, Carlo, Mazzitelli, Maria, Longhini, Federico, Garofalo, Eugenio, Bruni, Andrea, Giancotti, Aida, Barreca, Giorgio Settimo, Quirino, Angela, Liberto, Maria Carla, Serapide, Francesca, Matera, Giovanni, Trecarichi, Enrico Maria, Navalesi, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796355/
https://www.ncbi.nlm.nih.gov/pubmed/31619209
http://dx.doi.org/10.1186/s12879-019-4530-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796355/
https://www.ncbi.nlm.nih.gov/pubmed/31619209
http://dx.doi.org/10.1186/s12879-019-4530-1

Ejemplares similares